Hongli Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongli Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Arzoo N. Charania
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35249, USA
1 shared publication - Chao He
Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
1 shared publication - Cristian Coarfa
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
1 shared publication - Gang Liu
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, USA
1 shared publication - Huachun Cui
Division of Pulmonary, Allergy, and Critical Care Medicine Department of Medicine University of Alabama at Birmingham 35294 Birmingham AL USA
1 shared publication - Ivan O. Rosas
Baylor College of Medicine
1 shared publication
Latest Publications
- Open Access
- 30 May 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (6) , 365
Secreted Phosphoprotein 1 in Lung Diseases
Secreted phosphoprotein 1 (SPP1), also known as osteopontin (OPN) or early T lymphocyte activation protein 1 (ETA-1), is a multifunctional protein involved in numerous biological processes, including immune modulation, stress response, and tissue remodeling. The role of SPP1 in interstitial lung diseases (ILDs) has become an area of increasing interest, given its elevated expression in various ILDs such as idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD (CTD-ILD), and pneumoconiosis, especially with recent data derived from single-cell RNA sequencing. In addition to ILDs, SPP1 has been implicated in infectious granulomatous lung diseases, lung and pleural malignancies, airway diseases, and COVID-19. In most cases, higher SPP1 levels in serum, bronchoalveolar lavage fluid, or lung tissue carry a poor prognosis. SPP1 is expressed in multiple cells critical for fibrogenesis, including macrophages, epithelial cells, and fibroblasts, and SPP1 has emerged as a potential target for therapeutic interventions. Here, we review the proposed mechanisms by which SPP1 contributes to the development of lung disease, with an emphasis on ILD.
- 30 May 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (6) , 365
Open AccessSecreted Phosphoprotein 1 in Lung Diseases
Secreted phosphoprotein 1 (SPP1), also known as osteopontin (OPN) or early T lymphocyte activation protein 1 (ETA-1), is a multifunctional protein involved in numerous biological processes, including immune modulation, stress response, and tissue remodeling. The role of SPP1 in interstitial lung diseases (ILDs) has become an area of increasing interest, given its elevated expression in various ILDs such as idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD (CTD-ILD), and pneumoconiosis, especially with recent data derived from single-cell RNA sequencing. In addition to ILDs, SPP1 has been implicated in infectious granulomatous lung diseases, lung and pleural malignancies, airway diseases, and COVID-19. In most cases, higher SPP1 levels in serum, bronchoalveolar lavage fluid, or lung tissue carry a poor prognosis. SPP1 is expressed in multiple cells critical for fibrogenesis, including macrophages, epithelial cells, and fibroblasts, and SPP1 has emerged as a potential target for therapeutic interventions. Here, we review the proposed mechanisms by which SPP1 contributes to the development of lung disease, with an emphasis on ILD.
- Open Access
- 1 January 2025
- Published by SCIE Publishing Limited in Fibrosis
- Vol. 3 (1) , 10004
The Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review
SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals.
- 1 January 2025
- Published by SCIE Publishing Limited in Fibrosis
- Vol. 3 (1) , 10004
Open AccessThe Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review
SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals.